(VIANEWS) – The Market ended the session with VIRBAC (VIRP.PA) jumping 10.69% to €336.50 on Tuesday while CAC 40 jumped 0.08% to €7,574.67.
VIRBAC’s last close was €304.00, 3.18% below its 52-week high of €314.00.
About VIRBAC
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Earnings Per Share
As for profitability, VIRBAC has a trailing twelve months EPS of €14.14.
PE Ratio
VIRBAC has a trailing twelve months price to earnings ratio of 23.8. Meaning, the purchaser of the share is investing €23.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.8%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1%, now sitting on 1.21B for the twelve trailing months.
Yearly Top and Bottom Value
VIRBAC’s stock is valued at €336.50 at 21:36 EST, higher than its 52-week high of €314.00.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 26, 2023, the estimated forward annual dividend rate is 1.32 and the estimated forward annual dividend yield is 0.49%.
Volume
Today’s last reported volume for VIRBAC is 9081 which is 63.09% above its average volume of 5568.
More news about VIRBAC (VIRP.PA).
